Drug Problems

Investigating the intersection of pharmaceutical dollars and federal policy.

Latest

Hearing Without Listening

analysis | December 16, 2020

Latest

FDA Panel Reviewing Pfizer Vaccine Leaves Out Some Experts Who Raised Concerns

investigation | December 9, 2020

FDA Whitewashes Warnings About Coronavirus Vaccine Trials

analysis | November 2, 2020
Some FDA Advisors Tapped to Review Coronavirus Vaccines Received Payments from Vaccine Companies

investigation | October 21, 2020
Coronavirus Relief Act Gives Drug Makers New Sway Over FDA

investigation | May 5, 2020
Following the (Drug) Money

investigation | May 5, 2020
Tainted Prescriptions: Big Pharma's Ties to Experts Advising Congress on Drug Costs

investigation | January 28, 2019
FDA Set Low Bar for Approval of Blood Thinners

analysis | December 12, 2016
Drug Money: FDA Depends on Industry Funding; Money Comes with “Strings Attached”

investigation | December 1, 2016
Drug Money: In FDA Meetings, "Voice" of the Patient Often Funded by Drug Companies

investigation | December 1, 2016